Furthermore, the anti-obesity effect of PRLE was mechanistically associated with the downregulation of key transcription factors, including PPARγ and C/EBPα, underscoring its distinct action through the inhibition of adipogenesis. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.